Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallis

Showing results (311-320 of 476) with videos related to

Pageof 48
Sort By:
The Journal of Antimicrobial Chemotherapy|December 13, 2024
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2024
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2022
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection modelIain J Abbott, Elke van Gorp, Hugh Cottingham, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2017
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluentSaiyuri Naicker, Yarmarly C Guerra Valero, Jenny L Ordenez Meija, et al.
Bioanalysis|June 16, 2017
An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluentSuzanne L Parker, Yarmarly C Guerra Valero, Jenny L Ordóñez Mejia, et al.
Critical Care (London, England)|January 31, 2015
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyKiran Shekar, John F Fraser, Fabio Silvio Taccone, et al.
Anaesthesia and Intensive Care|December 9, 2025
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapyJessica H Xu, Sam Salman, David Jr Morgan, et al.
Journal of Periodontology|September 19, 2023
An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept studySrinivas Sulugodu Ramachandra, Fekade Bruck Sime, Saiyuri Naicker, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2024
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection modelIain J Abbott, Connor R B Anderson, Elke van Gorp, et al.
Plos One|September 20, 2023
Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgeryAhmad Alli, Fathima Paruk, Claire Roger, et al.
Pageof 48

Showing results (311-320 of 476) with videos related to

Sort By:
Pageof 48
The Journal of Antimicrobial Chemotherapy|December 13, 2024
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2024
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2022
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection modelIain J Abbott, Elke van Gorp, Hugh Cottingham, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2017
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluentSaiyuri Naicker, Yarmarly C Guerra Valero, Jenny L Ordenez Meija, et al.
Bioanalysis|June 16, 2017
An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluentSuzanne L Parker, Yarmarly C Guerra Valero, Jenny L Ordóñez Mejia, et al.
Critical Care (London, England)|January 31, 2015
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyKiran Shekar, John F Fraser, Fabio Silvio Taccone, et al.
Anaesthesia and Intensive Care|December 9, 2025
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapyJessica H Xu, Sam Salman, David Jr Morgan, et al.
Journal of Periodontology|September 19, 2023
An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept studySrinivas Sulugodu Ramachandra, Fekade Bruck Sime, Saiyuri Naicker, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2024
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection modelIain J Abbott, Connor R B Anderson, Elke van Gorp, et al.
Plos One|September 20, 2023
Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgeryAhmad Alli, Fathima Paruk, Claire Roger, et al.
Pageof 48